An individual with multiple sc …
Read News ArticleCategory: Latest News
MS Conversations Recognized as One of the Best MS Blogs of 2017 by Healthline
The Multiple Sclerosis Associa …
Read News ArticleFDA Approves First Drug to Treat Two Forms of MS
On March 28, 2017, the United …
Read News ArticleMarch is Multiple Sclerosis Awareness Month
The Multiple Sclerosis Association of America (MSAA) recognizes March as MS Awareness Month with the debut of MSAA’s Changing Lives Monday to Sunday video. This video highlights the many ways MSAA’s free programs and services positively impact the MS community.
Read News ArticlePatient Access Network (PAN) Foundation and MSAA Launch Alliance to Support People Living with MS
The Patient Access Network (PA …
Read News ArticleIra Levee Appointed to the Multiple Sclerosis Association of America’s Board of Directors
The Multiple Sclerosis Associa …
Read News ArticleMultiple Sclerosis Association of America and Antidote Technologies Team Up to Increase Awareness of Clinical Trials
The Multiple Sclerosis Association of America (MSAA), a national nonprofit organization and leading resource for the MS community, and Antidote Technologies, a digital health company, have announced a partnership to increase awareness of MS clinical trials and enable people to easily access this important information. The Antidote Match clinical trial search tool will now be available on MSAA’s website, allowing visitors to find trials that are right for them or their loved ones in minutes, just by answering a few questions.
Read News ArticleNew Chairman Elected to the Multiple Sclerosis Association of America’s Board of Directors
The Multiple Sclerosis Associa …
Read News ArticleOcrevus™ (Ocrelizumab) Phase III Trial Results Published
The results from three Phase I …
Read News ArticleFDA Extends Review of Ocrevus™ (ocrelizumab)
On December 20, 2016, Genentec …
Read News Article